A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations

There are now more therapeutic options for the treatment of rheumatoid arthritis (RA) than ever before, involving a range of mechanisms of action and different routes of administration. The T-cell costimulation modulator abatacept is the first biologic therapy for RA to be available in both subcutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wells, Alvin F, Jodat, Nicole, Schiff, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933241/
https://www.ncbi.nlm.nih.gov/pubmed/24600202
http://dx.doi.org/10.2147/BTT.S55783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933241/
https://www.ncbi.nlm.nih.gov/pubmed/24600202
http://dx.doi.org/10.2147/BTT.S55783

Ejemplares similares